Replies to post #78 on Orexigen Therapeutics Inc fka OREX

[SMaturin]

Yes, and in six months, they still will not yet have FDA approval to market the product, which is due Jan 31, 2011.

What target price would you guess when they actually market Contrave and have real revenue to report?

It will get into double digits pretty fast, is my bet. So 12 months from now, $20-30 range?

Good time to buy now from a long-term cap gain/tax perspective.